文献速递甲状腺疾病

分化型甲状腺癌主动监测与甲状腺手术比较:一项系统综述

Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review.
PubMed 文献 · Thyroid · 2022-03-17

该系统综述检索了Ovid MEDLINE、Embase和Cochrane Central,评估主动监测与立即手术对分化型甲状腺癌的获益与危害,以更新美国甲状腺协会指南。共纳入7项主动监测与立即手术比较研究及7项主动监测无对照治疗系列。低风险小癌中两种策略的全因或癌特异死亡率、远处转移及术后复发风险相似,但方法学局限使结论强度受限。

要点

  • 低风险小分化型甲状腺癌中,主动监测与立即手术的全因或癌特异死亡率、远处转移及术后复发风险相似且均低。
  • 主动监测患者肿瘤增长率低,后续手术率不一,且多因患者偏好而非肿瘤进展。
  • 手术较非手术管理全因或甲状腺癌死亡率改善,但受年龄、肿瘤风险类别及指征混杂影响,解读困难。

核心结论

  • 在小(主要≤1 cm)低风险(主要为乳头状)分化型甲状腺癌患者中,主动监测与立即手术可能伴随相似的死亡率、复发风险及其他结局,但方法学局限使无法得出强结论。
  • 非手术与手术比较的研究因临床异质性和潜在混杂因素难以解读,不适合评估主动监测的效用。
  • 需要研究以明确主动监测的获益与危害,并确定非乳头状分化型甲状腺癌、较大(>1 cm)肿瘤及老年患者中的结局。

研究设计与样本

  • 系统综述,检索Ovid MEDLINE、Embase和Cochrane Central(2021年7月),纳入主动监测与立即手术比较的研究,并单独评估手术与不手术治疗分化型甲状腺癌的研究以评估与主动监测的相关性。
  • 纳入7项主动监测与立即手术比较研究(5项队列研究,N=5432;2项横断面研究,N=538)及7项主动监测无对照治疗系列(N=1219)。
  • 1项横断面研究质量评级为fair,其余研究质量评级为poor;证据采用叙述性综合。

主要发现

  • 低风险(主要为乳头状)、小(主要≤1 cm)分化型甲状腺癌患者中,主动监测与立即手术的全因或癌特异死亡率、远处转移及术后复发风险相似且均低。
  • 主动监测无对照治疗系列报告低风险分化型甲状腺癌接受主动监测者无死亡病例。
  • 主动监测患者中肿瘤增长率低;后续手术率不一,且主要因患者偏好而非肿瘤进展。
  • 4项队列研究(N=88,654)发现,与不手术管理相比,手术与全因或甲状腺癌死亡率改善相关,但发现可能受患者年龄和肿瘤风险类别影响,且高度易受指征混杂、主动监测资格与接受情况以及手术时机不明确的影响。

局限性

  • 1项横断面研究质量评级为fair,其余研究质量评级为poor。
  • 方法学局限使无法得出强结论。
  • 非手术与手术比较的研究因临床异质性和潜在混杂因素难以解读,不适合评估主动监测的效用。
  • 手术与不手术比较的发现可能受患者年龄和肿瘤风险类别影响,且高度易受指征混杂、主动监测资格与接受情况以及手术时机不明确的影响。
  • 需要研究以明确主动监测的获益与危害,并确定非乳头状分化型甲状腺癌、较大(>1 cm)肿瘤及老年患者中的结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Active surveillance has been proposed as an appropriate management strategy for low-risk differentiated thyroid cancer (DTC), due to the typically favorable prognosis of this condition. This systematic review examines the benefits and harms of active surveillance vs. immediate surgery for DTC, to inform the updated American Thyroid Association guidelines. Methods: A search on Ovid MEDLINE, Embase, and Cochrane Central was conducted in July 2021 for studies on active surveillance vs. immediate surgery. Studies of surgery vs. no surgery for DTC were assessed separately to evaluate relevance to active surveillance. Quality assessment was performed, and evidence was synthesized narratively. Results: Seven studies (five cohort studies [N = 5432] and two cross-sectional studies [N = 538]) of active surveillance vs. immediate surgery, and seven uncontrolled treatment series of active surveillance (N = 1219) were included. One cross-sectional study was rated fair quality, and the remainder were rated poor quality. In patients with low risk (primarily papillary), small (primarily ≤1 cm) DTC, active surveillance, and immediate surgery were associated with similar, low risk of all-cause or cancer-specific mortality, distant metastasis, and recurrence after surgery. Uncontrolled treatment series reported no cases of mortality in low-risk DTC managed with active surveillance. Among patients managed with active surveillance, rates of tumor growth were low; rates of subsequent surgery varied and primarily occurred due to patient preference rather than tumor progression. Four cohort studies (N = 88,654) found that surgery associated with improved all-cause or thyroid cancer mortality compared with nonsurgical management, but findings were potentially influenced by patient age and tumor risk category and highly susceptible to confounding by indication; eligibility for, and receipt of, active surveillance; and timing of surgery was unclear. Conclusions: In patients with small low-risk (primarily papillary) DTC, active surveillance and immediate surgery may be associated with similar mortality, risk of recurrence, and other outcomes, but methodological limitations preclude strong conclusions. Studies of no surgery vs. surgery are difficult to interpret due to clinical heterogeneity and potential confounding factors and are unsuitable for assessing the utility of active surveillance. Research is needed to clarify the benefits and harms of active surveillance and determine outcomes in nonpapillary DTC, larger (>1 cm) cancers, and older patients.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Chou R, Dana T, Haymart M, et al. Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. Thyroid. 2022. PMID: 35081743. doi:10.1089/thy.2021.0539

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。